Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.89 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.68 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13700185 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL17602934 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL7155278 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL1952876 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL13700201 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL7155271 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL13700183 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL1026398 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL13700182 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 | |
| SCHEMBL13700164 | 1.00 | ACHE (0.89) | ACHEEPHX1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-100387339-C | Use of tin derivatives as catalysts for the transesterification of carbamates, carbamate compositions containing said catalysts and process for the transesterification of carbamates | RHODIA CHIMIE SA (FR) | 2008-05-14 | — | — | CN | disclosed |
| US-6998364-B2 | Process for the formation of urethane via transcarbamation | RHODIA CHIMIE (FR) | 2006-02-14 | — | — | US | disclosed |
| US-20040044242-A1 | Use as catalyst for forming urethanes,of fluorinated and of trivalent metal acid salts, composition containing same and methods using same | VENCOREX FRANCE (FR) | 2004-03-04 | — | — | US | disclosed |
| CN-1469777-A | Use of tin derivatives as catalysts for transforming carbamates, carbamate compositions comprising said catalyst and method for transforming carbamates | �Ϻ���ͨ��ѧ | 2004-01-21 | — | — | CN | disclosed |
| CN-1469888-A | Use as catalyst for forming urethanes, of fluorinated and trivalent metal acid salts, composition containing same and methods using same | ���ǻ�ѧ��˾ | 2004-01-21 | — | — | CN | disclosed |
| US-4713476-A | REACTING DI- OR POLYAMINE, UREA AND ALCOHOL | BASF AKTIENGESELLSCHAFT (DE) | 1987-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044242-A1 | Use as catalyst for forming urethanes,of fluorinated and of trivalent metal acid salts, composition containing same and methods using same | PHF2, UBE2T, UHRF1 | ACHE 877/4885EPHX1 3358/4885EPHX2 2676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.